Evidence map›Paper›PMID 32633957›Full record

ArticleJournal of chemical information and modeling2020

Discovery of Novel Small-Molecule Calcium Sensitizers for Cardiac Troponin C: A Combined Virtual and Experimental Screening Approach.

William H Coldren, Svetlana B Tikunova, Jonathan P Davis, Steffen Lindert

Open access · greenAbstract read
In one paragraph

Article in Journal of chemical information and modeling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 29 citations in OpenAlex.

  1. Review
  2. Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C.International journal of molecular sciences · 2023
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Gaussian accelerated molecular dynamics (GaMD): principles and applications.Wiley interdisciplinary reviews. Computational molecular science
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

William H ColdrenDepartment of Chemistry and Biochemistry, Ohio State University, Columbus, Ohio 43210, United States.ORCID 0000-0003-2260-3809
Svetlana B TikunovaDavis Heart and Lung Research Institute and Department of Physiology and Cell Biology, Ohio State University, Columbus, Ohio 43210, United States.
Jonathan P DavisDavis Heart and Lung Research Institute and Department of Physiology and Cell Biology, Ohio State University, Columbus, Ohio 43210, United States.
Steffen LindertDepartment of Chemistry and Biochemistry, Ohio State University, Columbus, Ohio 43210, United States.ORCID 0000-0002-3976-3473
The Ohio State University · US

Funding

Molecular models to characterize actions of calcium sensitizing drugsR01HL137015 · NHLBI · OHIO STATE UNIVERSITY · PI LINDERT, STEFFEN · 2018 to 2022
$1.8M
Role of Cardiac Troponin in Health and DiseaseR01HL132213 · NHLBI · OHIO STATE UNIVERSITY · PI DAVIS, JONATHAN PAUL · 2017 to 2020
$1.5M
NHLBI NIH HHS R01 HL132213NHLBI NIH HHS R01 HL137015
6 · The paper itself

Abstract

Heart failure is a leading cause of death throughout the world and is triggered by a disruption of the cardiac contractile machinery. This machinery is regulated in a calcium-dependent manner by the protein complex troponin. Calcium binds to the N-terminal domain of cardiac troponin C (cNTnC) setting into motion the cascade of events leading to muscle contraction. Because of the severity and prevalence of heart failure, there is a strong need to develop small-molecule therapeutics designed to increase the calcium sensitivity of cardiac troponin in order to treat this devastating condition. Molecules that are able to stabilize an open configuration of cNTnC and additionally facilitate the binding of the cardiac troponin I (cTnI) switch peptide have the potential to enable increased calcium sensitization and strengthened cardiac function. Here, we employed a high throughput virtual screening methodology built upon the ability of computational docking to reproduce known experimental results and to accurately recognize cNTnC conformations conducive to small molecule binding using a receiver operator characteristic curve analysis. This approach combined with concurrent stopped-flow kinetic experimental verification led to the identification of a number of sensitizers, which slowed the calcium off-rate. An initial hit, compound

Indexed as

CalciumTroponin CMolecular ConformationProtein BindingTroponin ICalciumTroponin CTroponin I

Identifiers

PMID32633957
PMCPMC7429331
OpenAlexW3038273828

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.